LOT 6 — Operational Efficiency

BritiAI response — NHS SBS Healthcare AI Solutions Open Framework (SBS10523)

Award criteria: Quality 90% / Social Value 10%. No cost weighting applied at framework level. This is a quality-led lot. BritiAI has written this response on the assumption that the evaluator is a Trust Chief Clinical Information Officer, a Chief Digital Information Officer, or a Director of Operations who has seen the ambient-documentation pitch deck five times already this quarter. Every paragraph below is intended to differentiate, not to repeat.


6.1 Why BritiAI wins Lot 6

The most-cited frustration in successive NHS Staff Surveys, GMC trainee returns and Royal College workforce reports is the same: administrative load on clinical staff. The market response from AI vendors has been almost uniform — an ambient-listening product that routes audio through United States cloud infrastructure, returns a structured note, and charges per clinician per month at a price point that comfortably exceeds many Trusts’ entire digital transformation budgets if scaled across a directorate.

BritiAI rejects that model on three grounds. It is not sovereign: audio leaves the Trust boundary, often the country. It is not affordable at scale: pricing assumes pilot deployment to a handful of senior clinicians, not routine adoption across an entire pathway. And it is not clinically governed by design: Trusts inherit clinical safety responsibility on systems whose internal behaviour the vendor will not document.

The BritiAI Lot 6 offer is built deliberately against each of those failings. Scribe-On-Site runs ambient capture and summarisation on the Trust’s own infrastructure using Votee’s V-Note on-prem engine, wrapped in the BritiAI Copilot for note structuring and SNOMED-aligned coding suggestions, and is priced to be affordable for routine deployment across a whole directorate. WardFlow Copilot brings agentic discharge orchestration into the existing EHR workflow rather than asking the Trust to adopt a parallel system. Atlas for Trusts gives clinical and operational staff a single, audited place to ask a question of every policy, SOP, guideline and learning log the Trust holds — and to receive an answer with a citation, not a hallucination. FOI & Complaints Auto-Triage removes a measurable, low-clinical-risk administrative burden from corporate services without touching the clinical frontline.

These solutions are productised. They are not bespoke consulting engagements masquerading as software. They are designed to be bought once and deployed many times across the NHS estate. That is the basis on which BritiAI proposes to enter this framework.

6.2 Named solutions under Lot 6

(i) Scribe-On-Site — On-Premises Ambient Clinical Documentation

Scribe-On-Site combines Votee V-Note (ambient speech capture and transcription) with the BritiAI Automated Speech Recognition stack and the BritiAI Copilot (note structuring, SNOMED coding suggestions, draft letter generation) in a single deployable bundle. The entire pipeline runs inside the Trust’s network — on Trust infrastructure or on a UK-sovereign private cloud tenancy contracted directly to the Trust. No clinical audio, transcript, or derived embedding leaves the Trust boundary at any point in the lifecycle.

The solution is delivered against a DCB0129-aligned Clinical Safety Case, with a named BritiAI Clinical Safety Officer engaged with the Trust’s own CSO from week one of deployment. The system is positioned as clinician-supporting, not clinician-replacing: every note, code suggestion and drafted letter requires the responsible clinician’s sign-off before it enters the patient record.

Target KPI: ≥60 minutes per clinician per day of documentation time reclaimed, measured at 90 days from go-live against a Trust-agreed baseline. Deployment to first clinical user: 8 weeks from call-off.

(ii) WardFlow Copilot — Agentic Discharge Orchestration

WardFlow Copilot is an agentic workflow that drafts the discharge summary directly from the EHR record, identifies and books to-take-out medications, flags clinical and operational blockers to the discharge co-ordinator, and routes the completed draft to the responsible consultant for sign-off. The agent operates with full audit logging of every action taken and every clinical document consulted. It does not prescribe, it does not diagnose, and it does not discharge — it removes the clerical load that today sits between the clinical decision to discharge and the patient actually leaving the ward.

Target KPIs: ≥25% reduction in median discharge-letter cycle time, and ≥10 percentage point improvement in TTO compliance, both at 90 days from go-live.

(iii) Atlas for Trusts — Trust-Wide Neural Memory Layer

Atlas for Trusts deploys the Beever Atlas neural memory layer as a single, audited retrieval and reasoning surface over the Trust’s institutional knowledge: clinical policies, standard operating procedures, locally-agreed guidelines, mortality and morbidity notes, learning-from-incident reports, induction materials, and any other corpus the Trust nominates. Beever Atlas is not a generic RAG wrapper around a hyperscaler model — it is an open-source neural memory architecture with peer-reviewed research published at ACL 2025 by the Beever laboratory in collaboration with HKUST, the Vector Institute, Stanford and the University of Waterloo. Every answer Atlas returns carries a citation to the source document; every query is logged for audit.

Target KPI: ≥40% reduction in median time-to-find for clinical and operational queries, measured against a Trust-agreed baseline at 90 days from go-live.

(iv) FOI & Complaints Auto-Triage

A deliberately low-clinical-risk entry point for Trusts seeking an early operational win. Incoming Freedom of Information requests and Patient Advice & Liaison Service complaints are classified, summarised, routed to the responsible team, and partially drafted, with a human-in-the-loop sign-off on every response. The solution sits inside the corporate function and does not touch the clinical record.

Target KPI: ≥50% reduction in median triage time at 60 days from go-live, with zero increase in the rate of upheld complaints or ICO referrals.

6.3 Evidence base

BritiAI’s claims under Lot 6 are evidenced, not asserted.

  • Votee V-Note is in production deployment across enterprise, government and financial services clients, including under the Hong Kong Monetary Authority’s FSS 3.1 pilot programme. The Votee Chief Scientist is the former Dean of the Deloitte AI Institute. The MAGIC training platform that underpins V-Note received the Baidu Innovation Award 2026.
  • Beever Atlas is open-source, with a published adopter community and benchmarked retrieval performance reported in the Beever laboratory’s peer-reviewed publications. ACL 2025 publications from the Beever lab include TheoremExplainAgent and HKCanto-Eval, both of which establish methodological credibility for the agentic and evaluation approaches BritiAI applies in WardFlow and Atlas respectively.
  • BritiAI Copilot and Document Processing are in production across financial services claims-handling and legal document review use cases, with case studies appended to this submission as evidence of comparable workflow complexity outside healthcare.
  • Clinical Safety: a DCB0129-aligned Clinical Safety Case template, hazard log, and Clinical Risk Management Plan are operated under BritiAI’s manufacturer Clinical Safety Management System. A named Clinical Safety Officer is appointed for this framework and identified in the supporting documentation.

6.4 Outcome commitments

BritiAI commits to the following KPIs in writing under any Lot 6 call-off. Each is measured against a baseline agreed in writing with the Trust SRO during the Diagnose phase, and reported in a published KPI report at the end of the Demonstrate phase.

SolutionCommitted KPIMeasurement window
Scribe-On-Site≥60 minutes per clinician per day reclaimed90 days from go-live
WardFlow Copilot≥25% reduction in discharge-letter cycle time; ≥10pp TTO improvement90 days from go-live
Atlas for Trusts≥40% reduction in median time-to-find90 days from go-live
FOI & Complaints Auto-Triage≥50% reduction in median triage time; zero increase in upheld complaints60 days from go-live

Each commitment is available under outcome-linked pricing on request: a defined portion of the call-off fee is held back and released only against documented achievement of the KPI. BritiAI is willing to carry that commercial risk because the engineering claim sits behind it.

6.5 Delivery model

BritiAI delivers every Lot 6 solution against its four-stage NHS programme model, which Trust SROs will recognise from any major change programme:

  1. Diagnose (Weeks 1–2). DTAC v2-aligned readiness assessment, data flow mapping, use-case prioritisation against the Trust’s strategic objectives, baseline KPI measurement agreed in writing.
  2. Design (Weeks 3–4). Solution architecture, Clinical Safety Case kick-off under DCB0129, Data Protection Impact Assessment, formal success metrics signed off by the SRO and the responsible CCIO.
  3. Deploy (Weeks 5–10). Sprint-based deployment with a named on-site BritiAI delivery lead, weekly clinical engagement sessions, twice-weekly executive read-outs, daily stand-up cadence with Trust digital and clinical teams.
  4. Demonstrate (Weeks 11–12). Published KPI report against the agreed metric, formal transition to business-as-usual, optional embedded operating partner under Lot 7.

6.6 Information governance, cyber and data residency

Every Lot 6 solution is operated under the following posture, flowed down to Votee and Beever as named sub-processors under the BritiAI Teaming Agreement:

  • UK data residency by default. Inference and storage are UK-only. On-premises deployment is supported for every productised Lot 6 solution.
  • NHS Data Security and Protection Toolkit: registered, working toward Standards Met under the current submission window.
  • ISO 27001:2022: Stage 1 in flight, with a documented roadmap to certification by Q4 2026.
  • Cyber Essentials Plus: assessment scheduled by 18 June 2026.
  • UK GDPR / DPA 2018: compliant, ICO-registered.
  • DCB0129 / DCB0160: every solution ships with a Clinical Safety Case, Hazard Log, and Clinical Risk Management Plan, and engages with the Trust’s DCB0160 process from the Design phase onward.

6.7 Why this answer is different

A Trust evaluator scoring this response should weigh five points.

Sovereign by design. Every solution can be deployed inside the Trust boundary on-premises. There is no asterisk and no later configuration step.

Clinically safe without overclaiming. BritiAI scopes its Lot 6 solutions explicitly outside Class IIa medical device territory and operates a manufacturer Clinical Safety Management System aligned to DCB0129. The CSO is named in the bid documentation.

Evidence-grade. Beever Atlas is open-source with ACL 2025 peer-reviewed publications behind it. V-Note is in regulated-sector production. BritiAI Copilot has comparable workflow case studies in financial and legal services. No claim in this response rests on a vendor demo.

Embedded, not delivered. The Lot 7 Fractional CAIO wrap is available as an option against any Lot 6 call-off, giving the Trust senior AI leadership inside its own governance for the duration of the deployment.

Buy-once, deploy-many. These are productised SKUs with a defined deployment pattern, a defined KPI, and a defined cost envelope. They are not a wrapper around a billable consulting day rate.

BritiAI is asking for a place on Lot 6 so that NHS Approved Organisations can buy ambient documentation, agentic discharge support, institutional memory and corporate-services triage from a single UK supplier, hold that supplier to a written outcome, and deploy the result inside their own network. That is the offer for this lot.